Pictures of bioavailability of liposomal glutathione
Thus, Sudakov and colleagues showed that DSIP-caused activation of neurons at the sensorimotor cortex, dorsal hippocampus, ventral thalamic nuclei, and lateral hypothalamus could be explained by its action on NMDA receptors of these structures [50]
They found that in people with autism, the drug boosts brain levels of gamma-aminobutyric acid (GABA), which dampens brain signals, relative to levels of glutamate, which excites brain activity
West Lafayette, Indiana, USA: Purdue University
Biopharma companies with GLP-1 (glucagon-like peptide-1) analogs, which have become a new trend in the obesity treatment market long dominated by appetite suppressants and fat-absorbance inhibitors, are upgrading their treatments